{"transactions":[{"id":1319048,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-02T21:44:15.000Z","date":"2024-12-31","kind":"sale","planned":false,"acquired":false,"shares":5400,"price":8,"value":43200.0,"ownership":{"direct":true},"balance_after":51760,"source":{"system":"sec-edgar","filing":"0001593968-25-000010","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000010/primary_01.xml","form_type":"4"}},{"id":1319047,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-02T21:44:15.000Z","date":"2024-12-24","kind":"sale","planned":false,"acquired":false,"shares":4600,"price":8.48,"value":39008.0,"ownership":{"direct":true},"balance_after":57160,"source":{"system":"sec-edgar","filing":"0001593968-25-000010","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000010/primary_01.xml","form_type":"4"}},{"id":1469888,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-25T20:12:06.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":7500,"price":14.09,"value":105675.0,"ownership":{"direct":true},"balance_after":61760,"source":{"system":"sec-edgar","filing":"0001593968-24-000910","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000910/primary_01.xml","form_type":"4"}},{"id":1472461,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-21T20:21:35.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":1107,"price":14.28,"value":15807.96,"ownership":{"direct":true},"balance_after":69260,"source":{"system":"sec-edgar","filing":"0001593968-24-000881","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000881/primary_01.xml","form_type":"4"}},{"id":1472460,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-21T20:21:35.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":6393,"price":13.62,"value":87072.66,"ownership":{"direct":true},"balance_after":70367,"source":{"system":"sec-edgar","filing":"0001593968-24-000881","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000881/primary_01.xml","form_type":"4"}},{"id":1479713,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:01:29.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10420,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-24-000858","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000858/primary_01.xml","form_type":"4"}},{"id":1479712,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:01:29.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":15.86,"value":247891.8,"ownership":{"direct":true},"balance_after":15630,"derivative":{"exercise_price":15.86,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0001593968-24-000858","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000858/primary_01.xml","form_type":"4"}},{"id":1479711,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:01:29.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":false,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001593968-24-000858","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000858/primary_01.xml","form_type":"4"}},{"id":1479710,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:01:29.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76760,"source":{"system":"sec-edgar","filing":"0001593968-24-000858","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000858/primary_01.xml","form_type":"4"}},{"id":1857768,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:49:15.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":6670,"derivative":{"underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001209191-23-036763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036763/doc4.xml","form_type":"4"}},{"id":1857767,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T20:49:15.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7710,"derivative":{"exercise_price":7.78,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":7710},"source":{"system":"sec-edgar","filing":"0001209191-23-036763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036763/doc4.xml","form_type":"4"}},{"id":1857766,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:49:15.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":false,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001209191-23-036763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036763/doc4.xml","form_type":"4"}},{"id":1857765,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T20:49:15.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":true,"shares":4600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":68590,"source":{"system":"sec-edgar","filing":"0001209191-23-036763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036763/doc4.xml","form_type":"4"}},{"id":2226058,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-22T00:50:44.000Z","date":"2022-06-17","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-22-038597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038597/doc4.xml","form_type":"4"}},{"id":2226057,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T00:50:44.000Z","date":"2022-06-17","kind":"exercise","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":63990,"source":{"system":"sec-edgar","filing":"0001209191-22-038597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038597/doc4.xml","form_type":"4"}},{"id":2233194,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-14T21:04:28.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":4600,"derivative":{"underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001209191-22-036744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036744/doc4.xml","form_type":"4"}},{"id":2233193,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T21:04:28.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 10, 2022 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":6900,"derivative":{"exercise_price":40.62,"exercise_date":"2023-06-10","expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001209191-22-036744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036744/doc4.xml","form_type":"4"}},{"id":2309353,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:14:37.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":300,"price":75.1033,"value":22530.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01 to $75.25, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":62590,"source":{"system":"sec-edgar","filing":"0001209191-22-022544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122022544/doc4.xml","form_type":"4"}},{"id":2309352,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:14:37.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":3255,"price":74.2501,"value":241684.0755,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.01 to $74.98, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":62890,"source":{"system":"sec-edgar","filing":"0001209191-22-022544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122022544/doc4.xml","form_type":"4"}},{"id":2309351,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:14:37.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":8945,"price":73.2867,"value":655549.5315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.98 to $73.91, inclusive. The reporting person undertakes to provide to Novavax, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":66145,"source":{"system":"sec-edgar","filing":"0001209191-22-022544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122022544/doc4.xml","form_type":"4"}},{"id":2451197,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-04T22:04:59.000Z","date":"2021-12-31","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.6,"exercise_date":"2012-09-01","expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-22-000955","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122000955/doc4.xml","form_type":"4"}},{"id":2451196,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T22:04:59.000Z","date":"2021-12-31","kind":"sale","acquired":false,"shares":3750,"price":144.1602,"value":540600.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.1004 to $144.37, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":75090,"source":{"system":"sec-edgar","filing":"0001209191-22-000955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122000955/doc4.xml","form_type":"4"}},{"id":2451195,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T22:04:59.000Z","date":"2021-12-31","kind":"exercise","acquired":true,"shares":3750,"price":25.6,"value":96000.0,"ownership":{"direct":true},"balance_after":78840,"source":{"system":"sec-edgar","filing":"0001209191-22-000955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122000955/doc4.xml","form_type":"4"}},{"id":2642089,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-06T21:06:09.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on January 1, 2021 and the remaining fifty percent (50%) vested on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on January 1, 2021 and the remaining fifty percent (50%) vested on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-045561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045561/doc4.xml","form_type":"4"}},{"id":2642088,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T21:06:09.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":75090,"source":{"system":"sec-edgar","filing":"0001209191-21-045561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121045561/doc4.xml","form_type":"4"}},{"id":2652455,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-29T21:11:30.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":7590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7590},"source":{"system":"sec-edgar","filing":"0001209191-21-043695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121043695/doc4.xml","form_type":"4"}},{"id":2652454,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-29T21:11:30.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":7590,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":65090,"source":{"system":"sec-edgar","filing":"0001209191-21-043695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121043695/doc4.xml","form_type":"4"}},{"id":2659490,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-22T21:13:37.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":1400,"derivative":{"underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-21-042447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042447/doc4.xml","form_type":"4"}},{"id":2659489,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:13:37.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 17, 2021 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":2600,"derivative":{"exercise_price":179.89,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001209191-21-042447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042447/doc4.xml","form_type":"4"}},{"id":2772400,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-25","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 12, 2019 grant date."}],"balance_after":0,"derivative":{"exercise_price":3.985,"exercise_date":"2020-12-12","expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772399,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 15, 2017 grant date."}],"balance_after":0,"derivative":{"exercise_price":27.6,"exercise_date":"2018-12-15","expiration_date":"2027-12-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772398,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") vested one (1) year from the December 13, 2018 grant date."}],"balance_after":0,"derivative":{"exercise_price":46,"exercise_date":"2019-12-13","expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772397,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-25","kind":"exercise","acquired":true,"shares":37500,"price":3.985,"value":149437.5,"ownership":{"direct":true},"balance_after":57500,"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772396,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-25","kind":"exercise","acquired":true,"shares":10000,"price":27.6,"value":276000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772395,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":2446,"price":229.4089,"value":561134.1694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.00 to $229.65, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772394,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":3120,"price":228.4171,"value":712661.352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.00 to $228.89, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":12446,"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772393,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":4434,"price":227.4324,"value":1008435.2616,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.00 to $227.61, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":15566,"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2772392,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T22:41:13.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":10000,"price":46,"value":460000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121023076/doc4.xml","form_type":"4"}},{"id":2922569,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-01-05T22:38:12.000Z","date":"2021-01-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fifty percent (50%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on January 1, 2021, and the remaining fifty percent (50%) of the RSUs subject to this grant will vest on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Fifty percent (50%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on January 1, 2021, and the remaining fifty percent (50%) of the RSUs subject to this grant will vest on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2922568,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T22:38:12.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":51.4,"exercise_date":"2011-10-19","expiration_date":"2021-04-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2922567,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T22:38:12.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":50,"exercise_date":"2011-09-10","expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2922566,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:38:12.000Z","date":"2021-01-01","kind":"exercise","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2922565,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:38:12.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":2000,"price":113.595,"value":227190.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.47 to $113.78, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2922564,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:38:12.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":9000,"price":112.9805,"value":1016824.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.45 to $113.43, inclusive. The reporting person undertakes to provide to Novavax, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2922563,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:38:12.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":10000,"price":51.4,"value":514000.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2922562,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:38:12.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":1000,"price":50,"value":50000.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-21-001380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001380/doc4.xml","form_type":"4"}},{"id":2954135,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-08T23:21:26.000Z","date":"2020-12-05","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, in connection with the appointment of the Reporting Person as Chair of a newly established standing Research and Development Committee of the Board of Directors of the Company. Fifty percent (50%) of the RSUs subject to this grant will vest on January 1, 2021, and the remaining fifty percent (50%) of the RSUs subject to this grant will vest on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This grant was made under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, in connection with the appointment of the Reporting Person as Chair of a newly established standing Research and Development Committee of the Board of Directors of the Company. Fifty percent (50%) of the RSUs subject to this grant will vest on January 1, 2021, and the remaining fifty percent (50%) of the RSUs subject to this grant will vest on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-062345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120062345/doc4.xml","form_type":"4"}},{"id":3099297,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-27T01:15:08.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":7590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7590,"derivative":{"underlying":"Common Stock","underlying_shares":7590},"source":{"system":"sec-edgar","filing":"0001209191-20-039190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120039190/doc4.xml","form_type":"4"}},{"id":3099296,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-06-27T01:15:08.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":15180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest one (1) year from the June 25, 2020 grant date (the \"Grant Date\"), subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":15180,"derivative":{"exercise_price":83.54,"exercise_date":"2021-06-25","expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":15180},"source":{"system":"sec-edgar","filing":"0001209191-20-039190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120039190/doc4.xml","form_type":"4"}},{"id":3121036,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-05T21:04:47.000Z","date":"2020-06-03","kind":"purchase","acquired":true,"shares":1500,"price":48.83,"value":73245.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001209191-20-034716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120034716/doc4.xml","form_type":"4"}},{"id":3197060,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-24T21:24:09.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person is amending the Form 4 originally filed solely to correct the number of stock options to purchase common stock of Novavax, Inc. (the \"Company\") acquired by the Reporting Person on December 12, 2019 under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"2015 Stock Plan\"), and the related number of stock options beneficially owned following the reported transaction, due to an inadvertent error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the shares subject to this option grant under the Company's 2015 Stock Plan will vest one (1) year from the December 12, 2019 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":37500,"derivative":{"exercise_price":3.99,"exercise_date":"2020-12-12","expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-20-020967","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120020967/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-16"}},{"id":3341384,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-12-16T21:57:07.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 12, 2019 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.99,"exercise_date":"2020-12-12","expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-060684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919119060684/doc4.xml","form_type":"4"}},{"id":3731238,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-12-14T21:47:01.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 13, 2018 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":200000,"derivative":{"exercise_price":2.3,"exercise_date":"2019-12-13","expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-062748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919118062748/doc4.xml","form_type":"4"}},{"id":4127157,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-12-19T21:10:17.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 15, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.38,"exercise_date":"2018-12-15","expiration_date":"2027-12-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-17-066312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117066312/doc4.xml","form_type":"4"}},{"id":4220005,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-01T20:27:44.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":175000,"price":1.0564,"value":184870.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.05 to $1.075, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-051058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117051058/doc4.xml","form_type":"4"}},{"id":4378471,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-03-20T20:13:15.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan will vest one (1) year from the March 16, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.38,"exercise_date":"2018-03-16","expiration_date":"2027-03-16","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-17-021703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117021703/doc4.xml","form_type":"4"}},{"id":4382976,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":84640,"kind":"person","name":"YOUNG JAMES F","position":1,"cik":"0001219864","reported_name":"YOUNG JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-16T20:19:54.000Z","date":"2017-03-14","kind":"sale","acquired":false,"shares":100000,"price":1.3898,"value":138980.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.395, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, he transferred 100,000 shares of Novavax common stock to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife."}],"balance_after":175000,"source":{"system":"sec-edgar","filing":"0001209191-17-021088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117021088/doc4.xml","form_type":"4"}}]}